Krystal Biotech
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.About KRYS
Krystal Biotech, Inc. operates as a biotechnology company, which engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK.
CEOKrish S. Krishnan
CEOKrish S. Krishnan
Employees275
Employees275
HeadquartersPittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded2016
Founded2016
Employees275
Employees275
KRYS Key Statistics
Market cap6.84B
Market cap6.84B
Price-Earnings ratio35.78
Price-Earnings ratio35.78
Dividend yield—
Dividend yield—
Average volume363.99K
Average volume363.99K
High today—
High today—
Low today—
Low today—
Open price$237.76
Open price$237.76
Volume0.00
Volume0.00
52 Week high$248.60
52 Week high$248.60
52 Week low$122.80
52 Week low$122.80
Stock Snapshot
Krystal Biotech(KRYS) stock is priced at $235.80, giving the company a market capitalization of 6.84B. It carries a P/E multiple of 35.78.
On 2025-12-18, Krystal Biotech(KRYS) stock opened at $237.76, reached a high of —, and a low of —.
The Krystal Biotech(KRYS)'s current trading volume is 0, compared to an average daily volume of 363.99K.
During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $248.60 at its peak.
During the past year, Krystal Biotech(KRYS) stock moved between $122.80 at its lowest and $248.60 at its peak.
KRYS News
Simply Wall St 6d
Krystal Biotech And 2 Other Growth Stocks Insiders Are Betting OnAs the U.S. stock market experiences a surge following the Federal Reserve's decision to cut interest rates, investors are closely watching growth companies wit...
Analyst ratings
92%
of 12 ratingsBuy
91.7%
Hold
8.3%
Sell
0%
People also own
Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.